Search research articles
Contact Us
Filters
Showing results (21-30 of 64) with videos related to
Page
of 7
Sort By:
Blood
|
November 26, 2008
Clinical differences between nasal and extranasal natural killer/T-cell lymphoma: a study of 136 cases from the International Peripheral T-Cell Lymphoma Project
Wing-yan Au, Dennis D Weisenburger, Tanin Intragumtornchai, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
April 28, 2021
<sup>18</sup>F-Fluorothymidine PET is an early and superior predictor of progression-free survival following chemoimmunotherapy of diffuse large B cell lymphoma: a multicenter study
Ryogo Minamimoto, Luis Fayad, Julie Vose, et al.
Blood Cancer Journal
|
February 14, 2018
Rac1 is a novel therapeutic target in mantle cell lymphoma
Tian Tian, Chengfeng Bi, Ashley L Hein, et al.
Journal of Oncology Practice
|
October 25, 2019
Assessing an ASCO Decision Aid for Improving the Accuracy and Attribution of Serious Adverse Event Reporting From Investigators to Sponsors
Kathryn F Mileham, Caroline Schenkel, Meredith K Chuk, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
July 27, 2010
The role of cytotoxic therapy with hematopoietic stem cell transplantation in the treatment of diffuse large B cell lymphoma: update of the 2001 evidence-based review
Denise M Oliansky, Myron Czuczman, Richard I Fisher, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
June 19, 2013
Does functional imaging distinguish nodular lymphocyte-predominant hodgkin lymphoma from T-cell/histiocyte-rich large B-cell lymphoma?
Nicholas A Barber, Fausto R Loberiza, Anamarija M Perry, et al.
British Journal of Haematology
|
April 15, 2011
Gains of MYC locus and outcome in patients with diffuse large B-cell lymphoma treated with R-CHOP
Monica Testoni, Ivo Kwee, Timothy C Greiner, et al.
American Journal of Clinical Pathology
|
December 22, 2010
The stromal cell marker SPARC predicts for survival in patients with diffuse large B-cell lymphoma treated with rituximab
Paul N Meyer, Kai Fu, Timothy Greiner, et al.
Nature Reviews. Clinical Oncology
|
December 30, 2016
The landscape of new drugs in lymphoma
Anas Younes, Stephen Ansell, Nathan Fowler, et al.
Journal of Global Oncology
|
September 23, 2018
American Society of Clinical Oncology's Global Oncology Leadership Task Force: Findings and Actions
Gabriel N Hortobagyi, Doug Pyle, Eduardo L Cazap, et al.
Page
of 7
Search research articles
Search
Showing results (21-30 of 64) with videos related to
Sort By:
Page
of 7
Blood
|
November 26, 2008
Clinical differences between nasal and extranasal natural killer/T-cell lymphoma: a study of 136 cases from the International Peripheral T-Cell Lymphoma Project
Wing-yan Au, Dennis D Weisenburger, Tanin Intragumtornchai, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
April 28, 2021
<sup>18</sup>F-Fluorothymidine PET is an early and superior predictor of progression-free survival following chemoimmunotherapy of diffuse large B cell lymphoma: a multicenter study
Ryogo Minamimoto, Luis Fayad, Julie Vose, et al.
Blood Cancer Journal
|
February 14, 2018
Rac1 is a novel therapeutic target in mantle cell lymphoma
Tian Tian, Chengfeng Bi, Ashley L Hein, et al.
Journal of Oncology Practice
|
October 25, 2019
Assessing an ASCO Decision Aid for Improving the Accuracy and Attribution of Serious Adverse Event Reporting From Investigators to Sponsors
Kathryn F Mileham, Caroline Schenkel, Meredith K Chuk, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
July 27, 2010
The role of cytotoxic therapy with hematopoietic stem cell transplantation in the treatment of diffuse large B cell lymphoma: update of the 2001 evidence-based review
Denise M Oliansky, Myron Czuczman, Richard I Fisher, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
June 19, 2013
Does functional imaging distinguish nodular lymphocyte-predominant hodgkin lymphoma from T-cell/histiocyte-rich large B-cell lymphoma?
Nicholas A Barber, Fausto R Loberiza, Anamarija M Perry, et al.
British Journal of Haematology
|
April 15, 2011
Gains of MYC locus and outcome in patients with diffuse large B-cell lymphoma treated with R-CHOP
Monica Testoni, Ivo Kwee, Timothy C Greiner, et al.
American Journal of Clinical Pathology
|
December 22, 2010
The stromal cell marker SPARC predicts for survival in patients with diffuse large B-cell lymphoma treated with rituximab
Paul N Meyer, Kai Fu, Timothy Greiner, et al.
Nature Reviews. Clinical Oncology
|
December 30, 2016
The landscape of new drugs in lymphoma
Anas Younes, Stephen Ansell, Nathan Fowler, et al.
Journal of Global Oncology
|
September 23, 2018
American Society of Clinical Oncology's Global Oncology Leadership Task Force: Findings and Actions
Gabriel N Hortobagyi, Doug Pyle, Eduardo L Cazap, et al.
Page
of 7